Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of AZARGA vs COMBIGAN on Circadian Ocular Perfusion Pressure in Open-Angle Glaucoma
2007-005936-99Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in open-angle glaucoma (OAG) comparing Azarga arm with Combigan arm (2 arms). Primary endpoint: Diastolic ocular perfusion pressure. Started Mar 2008; status: completed.
02
Drugs
brinzolamidebrimonidine tartrate + timolol maleate
03
Conditions
open-angle glaucoma (OAG)
Beyond the preview
Go deeper on 2007-005936-99.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005936-99.